Hospitalization and medication use in schizophrenia patients receiving risperidone long-acting injectable or oral atypical antipsychotic medication

被引：3
|
作者：
Chue, P
Lam, A
Chandra, K
Luong, D
Camacho, F
机构：
[1] Univ Alberta, Edmonton, AB, Canada
[2] Janssen Ortho Inc, Toronto, ON, Canada
[3] McKesson Phase 4 Solut, Toronto, ON, Canada
[4] Damos Inc, Toronto, ON, Canada
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)67768-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A202 / A202
页数：1
相关论文
共 50 条
  • [1] Hospitalization and medication use in schizophrenia patients receiving risperidone long-acting injectable or oral atypical antipsychotic medication
    Chue, P.
    Lam, A.
    Chandra, K.
    Luong, D.
    Camacho, F.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S263 - S263
  • [2] Impact of risperidone long-acting injectable on hospitalization and medication use in patients with schizophrenia
    Beauclair, L.
    Lam, A.
    McCormick, J.
    Luong, D.
    Camacho, F.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S263 - S263
  • [3] Impact of risperidone long-acting injectable on hospitalization and medication use in patients with schizophrenia
    Beauclair, L
    Lam, A
    McCormick, J
    Luong, D
    Camacho, F
    VALUE IN HEALTH, 2005, 8 (06) : A202 - A203
  • [4] Long-acting injectable antipsychotic medication after a first episode of schizophrenia
    不详
    EARLY INTERVENTION IN PSYCHIATRY, 2012, 6 : 7 - 7
  • [5] Neurocognition and attitudes to medication in risperidone long-acting injectable
    Penades, R.
    Catalan, R.
    Pujol, N.
    Navarro, V.
    Massana, G.
    Gasto, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S462 - S463
  • [6] Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection
    Emsley, Robin
    Oosthuizen, Petrus
    Koen, Liezl
    Niehaus, Dana J. H.
    Medori, Rossella
    Rabinowitz, Jonathan
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (06) : 325 - 331
  • [7] Long-Acting Antipsychotic Medication and the Outcome of Schizophrenia
    David, Anthony S.
    Gibbs, Ayana
    Patel, Maxine X.
    ADVANCES IN SCHIZOPHRENIA RESEARCH 2009, 2010, : 403 - +
  • [8] Long-acting injectable risperidone: Efficacy and safety of the first long-acting atypical antipsychotic
    Kane, JM
    Eerdekens, M
    Lindenmayer, JP
    Keith, SJ
    Lesem, M
    Karcher, K
    AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (06): : 1125 - 1132
  • [9] Expanding Therapy With Long-Acting Antipsychotic Medication in Patients With Schizophrenia
    Carpenter, William T., Jr.
    Buchanan, Robert W.
    JAMA PSYCHIATRY, 2015, 72 (08) : 745 - 746
  • [10] Long-acting, injectable risperidone - the first long-acting, atypical antipsychotic - improves quality of life
    Nasrallah, H
    Duchesne, I
    Mehnert, A
    Janagap, C
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S282 - S282
12345